ArticleESC heart failure2026
Timing-specific factors associated with early, intermediate, and late readmission after heart failure hospitalization.
Article in ESC heart failure, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
aimsTo identify factors associated with early, intermediate, and late readmission after heart failure hospitalization. METHODS AND
resultsThis secondary analysis included 1992 patients discharged alive from a single-centre Chinese heart failure cohort. Median age was 75 years (interquartile range 65-85), and 58.2% were female. Within 6 months, 776 patients (39.0%) were readmitted: 140 (7.0%) early (≤28 days), 358 (18.0%) intermediate (29-90 days), and 278 (14.0%) late (91-180 days). Early readmission was associated with biventricular heart failure (odds ratio 1.72; P = .022), New York Heart Association class IV (1.47; P = .043), estimated glomerular filtration rate <60 ml/min/1.73 m2 (1.64; P = .021), and hyponatraemia (1.71; P = .008). Intermediate readmission was associated with biventricular heart failure (1.68; P < .001), systolic blood pressure <110 mmHg (1.68; P < .001), and B-type natriuretic peptide ≥1000 pg/ml (1.32; P = .029). Late readmission was associated with dementia (2.30; P < .001), biventricular heart failure (1.69; P = .002), chronic kidney disease (1.56; P = .030), and diabetes (1.44; P = .043). Apparent areas under the curve were 0.677, 0.641, and 0.629 for early, intermediate, and late readmission, respectively.
conclusionsAssociated factors differed across post-discharge intervals but overlapped. Early readmission was associated with advanced heart failure severity and cardiorenal-electrolyte instability. Intermediate readmission was associated with haemodynamic compromise and cardiac stress. Late readmission demonstrated stronger associations with chronic comorbidity burden, alongside cognitive and systemic disease. Biventricular heart failure was associated with all three intervals. These findings require external validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.